Enanta Pharmaceuticals (NASDAQ:ENTA) issued its quarterly earnings data on Monday. The company reported $2.61 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.67 by $0.94. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) belongs to Healthcare sector. Its weekly performance is 4.49%. On last trading day company shares ended up $39.13. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) distance from 50-day simple moving average (SMA50) is -2.96%.
Chevron Corporation (NYSE: CVX) reported that it is pulling staff out of North Iraq as the Islamic State militants are pushing hard towards the capital. According to Chevron Corp, it has extracted expatriate staff from the location because of safety concerns.Chevron Corporation (NYSE:CVX) shares fell -0.49% in last trading session and ended the day at $127.09. CVX Gross Margin is 35.30% and its return on assets is 7.90%. Chevron Corporation (NYSE:CVX) quarterly performance is 1.85%.
Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited results from operations for both the third fiscal quarter and the nine months ended June 30, 2014. Corium’s fiscal year ends on September 30, 2014.On 12 August, Corium International, Inc. (NASDAQ:CORI) shares remains unchanged and was closed at $5.66. CORI EPS growth in last 5 year was 0.00%. Corium International, Inc. (NASDAQ:CORI) year to date (YTD) performance is -29.25%.
Heritage Oaks Bancorp (NASDAQ:HEOP) announced a quarterly dividend on Tuesday, July 29th. Shareholders of record on Friday, August 29th will be paid a dividend of 0.03 per share on Monday, September 15th. This represents a $0.12 annualized dividend and a dividend yield of 1.68%. The ex-dividend date is Wednesday, August 27th. Heritage Oaks Bancorp (NASDAQ:HEOP) ended the last trading day at $6.77. Company weekly volatility is calculated as 2.07%and price to cash ratio as 2.44. Heritage Oaks Bancorp (NASDAQ:HEOP) showed a weekly performance of -1.46%.
Fabrinet (NYSE:FN) CEO David T. Mitchell sold 40,000 shares of the company’s stock on the open market in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $18.35, for a total value of $734,000.00. Following the transaction, the chief executive officer now directly owns 266,905 shares in the company, valued at approximately $4,897,707. Fabrinet (NYSE:FN) shares fell -1.24% in last trading session and ended the day on $19.16. FN Gross Margin is 10.80% and its return on assets is 19.00%. Fabrinet (NYSE:FN) quarterly performance is -1.79%.